Rani Therapeutics Holdings (RANI) Return on Sales [ROS] (2020 - 2026)
Rani Therapeutics Holdings (RANI) reported Return on Sales [ROS] of -516.86% for Q2 2026, up 3589.39 percentage points from -4106.25% a year earlier but down 28.63 percentage points from the prior quarter.
Rani Therapeutics Holdings (RANI) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rani Therapeutics Holdings' Return on Sales [ROS] came in at -675.80%, up 3430.45 percentage points year-over-year; for FY2025, it came in at -2345.99%, up 2840.20 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +1234.96 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -5186.19% in FY2024 and -1899.12% in FY2021 (+1681.84 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of -6984.30% in Q1 2025 and a high of -488.23% in Q1 2026.
- Year over year, Return on Sales [ROS] has now increased in each of the last three quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -488.23% (Q1 2026), -584.19% (Q4 2025) and -3727.75% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Rani Therapeutics Holdings | 151.61 Mn | 160.36 Mn | - | -516.86% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -516.86% |
| Mar 31, 2026 | -488.23% |
| Dec 31, 2025 | -584.19% |
| Sep 30, 2025 | -3,727.75% |
| Jun 30, 2025 | -4,106.25% |
| Mar 31, 2025 | -6,984.30% |
| Dec 31, 2024 | -1,455.06% |
| Jun 30, 2022 | -3,608.87% |
| Dec 31, 2021 | -1,899.12% |
| Sep 30, 2021 | -1,475.26% |
| Jun 30, 2021 | -268.13% |
| Mar 31, 2021 | -687.57% |
| Dec 31, 2020 | -2,354.29% |
| Sep 30, 2020 | -2,617.59% |
| Jun 30, 2020 | -5,650.00% |
Rani Therapeutics Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();